Nanomedicines continue to accelerate the forefront of drug delivery technologies. Inorganic mesoporous silica nanoparticles are a driving force with their unique and superlative properties. Recently, formulation researches with mesoporous silica nanoparticles have advanced many drug delivery systems, including liposome, microsphere, oro-dispersible film, 3D-printed formulation, and microneedle. 

Dipy Vasa from Pfizer focuses this talk on mesoporus silica solubility-enabling technology background and examples, her teams current work, experimental setup, controlling drug release with HPMCAS and potential applications to this approach.

FREE WEBINAR: Tuning Drug Release from Mesoporus Silica Particles: Impact of HPMCAS Polymer

Dipy Vasa, PhD
  • LinkedIn
  • Twitter
  • Google+
  • Facebook
  • Pinterest
  • Print Friendly

Dipy Vasa, PhD

Senior Scientist, Drug Product Design


2021 Global Drug Bioavailability Enhancement Summit

(Nov 3 - 4, 2021)


Interested to improve the performance of your drug products? Learn 2 years of new drug product development approaches at the 2021 Global Drug Bioavailability Enhancement Virtual Summit this November.

Join 100's of leading drug delivery, formulation and development experts and hear 25+ expert sessions. Gain over 2 years worth of new drug product development strategies, formulation approaches, delivery technologies and regulatory updates while decreasing drug product time-to-market in just 2 short days (all available on-demand)!

Save over 10% on attendance registration before October 30th, 2021 (Only $449). Likewise, have a platform technology you would like to explore showcasing to the wider audience this November? Reach out below to find out remaining opportunities.

2021 On-Demand Summits Available for Purchase

(Limited time - Only $299)

Pin It on Pinterest

Share This

Share this with a friend or colleague!